3/3
12:17 pm
mrsn
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock.
Medium
Report
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock.
3/3
12:17 pm
mrsn
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock.
Medium
Report
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock.
2/6
07:33 am
mrsn
Mersana Therapeutics, Inc. (NASDAQ: MRSN) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Medium
Report
Mersana Therapeutics, Inc. (NASDAQ: MRSN) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
2/6
07:33 am
mrsn
Mersana Therapeutics, Inc. (NASDAQ: MRSN) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Medium
Report
Mersana Therapeutics, Inc. (NASDAQ: MRSN) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
2/6
06:07 am
mrsn
Rating for MRSN
Medium
Report
Rating for MRSN
2/6
06:07 am
mrsn
Rating for MRSN
Medium
Report
Rating for MRSN
2/6
05:00 am
mrsn
Mersana Therapeutics initiated with an Outperform at William Blair
Medium
Report
Mersana Therapeutics initiated with an Outperform at William Blair
2/6
05:00 am
mrsn
Mersana Therapeutics initiated with an Outperform at William Blair
Medium
Report
Mersana Therapeutics initiated with an Outperform at William Blair
2/5
04:44 pm
mrsn
Mersana Therapeutics initiated with an Outperform at William Blair
Medium
Report
Mersana Therapeutics initiated with an Outperform at William Blair
2/5
04:44 pm
mrsn
Mersana Therapeutics initiated with an Outperform at William Blair
Medium
Report
Mersana Therapeutics initiated with an Outperform at William Blair
1/10
08:13 pm
mrsn
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock, down previously from $7.00.
High
Report
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock, down previously from $7.00.
1/10
08:13 pm
mrsn
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock, down previously from $7.00.
High
Report
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock, down previously from $7.00.